Clinical studies show that GLP-1 medications like semaglutide can lead to an average loss of up to 14.9% of starting body weight over 68 weeks
Li QX, Gao H, Guo YX, Wang BY, Hua R, Gao L, et al
"For many older adults living on fixed incomes, an additional $50 per month, or $600 annually, is a substantial financial burden that may put treatment out of reach," Vafiadis says
The comorbidity multi-select is explicitly framed with an insurance-approval helper message: Having one or more of these medical conditions may improve the likelihood of insurance approval for GLP-1 medications, potentially reducing your out-of-pocket medication costs. The insurance selector later in the flow includes options most providers exclude Medicare , Medicare Advantage , Medicaid , and Tricare and the plan details explicitly mention prior-authorization assistance for brand-name medications like Ozempic and Wegovy